SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Maulcoin

Maulcoin is surging in community discussions as supporters rally behind recent ticker recovery and growing organic engagement. The community is actively pushing for a breakout, focusing on upcoming milestones and potential airdrops as they aim to establish the project within the broader meme coin ecosystem.

Aerodrome Finance is a next-generation AMM designed to serve as Base's central liquidity hub, combining a powerful liquidity incentive engine, vote-lock governance model, and friendly user experience. Aerodrome inherits the latest features from Velodrome V2.

Aerodrome Finance

Aerodrome Finance is currently surging as investors pivot toward the Base ecosystem, fueled by anticipation surrounding upcoming network events and a broader rotation of liquidity into decentralized exchanges. The community remains highly focused on the protocol's fee-generating utility and the long-term impact of its tokenomics model as traders position themselves for potential expansion in the coming cycles.

Grok's first token launched on Base, deployed directly on X with help of Bankr. Proof of deployment here, https://x.com/grok/status/1897949874961650169.  Join the DRB community if this story intrigues you, follow it as it unfolds into this new AI era.  Grok earns swap fees - Grok's trading wallet: 0xb1058c959987e3513600eb5b4fd82aeee2a0e4f9.  Articles, media coverages on $DRB featured here, https://linktr.ee/DRBtaskforce.  Our dev, is grok, one of the front-running candidate to achieve AGI.

DebtReliefBot

DRB is gaining traction as a high-conviction play within the Base ecosystem, with investors highlighting its unique link to AI-driven wealth and the narrative that Grok's own wallet holds the asset. The community is actively discussing the token's massive growth potential, often drawing comparisons to historical meme coin runs while emphasizing its status as an early-stage, under-the-radar opportunity.

Atlassian Corp. is a holding company, which engages in providing team collaboration and productivity software. Its products include Jira Software, Confluence, Jira Service Management, and Loom. The company was founded by Michael Cannon-Brookes and Scott Farquhar in October 2002 and is headquartered in San Francisco, CA.

Atlassian Corporation - Ordinary Shares - Class A

Atlassian Corporation Plc

Atlassian is trending following the announcement that SanDisk will replace it in the Nasdaq-100, fueling community debate about the long-term impact of AI on incumbent SaaS workflows and valuation. Investors are actively discussing the stock's sharp decline, weighing institutional de-risking and AI disruption fears against the company's deeply embedded enterprise utility and potential for future stabilization.

Global X Funds - Global X Silver Miners ETF

The Global X Silver Miners ETF (SIL) is drawing intense investor attention as silver prices reach historic highs, driven by a persistent supply deficit and strong industrial demand for the metal in AI, solar, and EV sectors. Market participants are actively debating the decoupling between silver's spot price and mining equities, with many looking for a dramatic catch-up rally in miners as the broader precious metals sector experiences increased volatility and record-breaking volume.

IDEAYA Biosciences, Inc. engages in the research and development of oncology-focused precision medicine. The firm focuses on the targeted therapeutics for patients selected using molecular diagnostics. Its product candidate, IDE196, is a protein kinase C inhibitor for genetically defined cancers having GNAQ and GNA11 gene mutations. The company was founded by Yujiro S. Hata and Jeffrey Hager in June 2015 and is headquartered in South San Francisco, CA.

Ideaya Biosciences Inc

Ideaya Biosciences is trending as investors gear up for the anticipated April 13th topline data readout from the Phase 2/3 OptimUM-02 trial evaluating Darovasertib and Crizotinib in metastatic Uveal Melanoma. The community is heavily focused on whether the Progression-Free Survival and Overall Response Rate results will meet the high bar required for an Accelerated Approval filing, with sentiment bolstered by strong institutional interest and the company's robust balance sheet.

Byrna Technologies, Inc. is a less-lethal self-defense technology company, which engages in the business of developing, manufacturing, and selling innovative less-lethal personal security solutions. It operates through the following geographical segments: the United States, South Africa, Europe, South America, and Asia, and Canada. The company was founded on March 1, 2005 and is headquartered in Andover, MA.

Byrna Technologies Inc

Byrna Technologies is trending as investors respond to significant production increases and rising demand for its non-lethal self-defense devices, fueled by a broader market interest in security-focused stocks. The community remains deeply divided, with some highlighting strong fundamental growth and retail expansion, while others voice concerns over short-selling volatility and the company's long-term competitive position.

Assertio Holdings, Inc. is a commercial pharmaceutical company, which engages in acquisitions, licensing, and mergers. The firm focuses on portfolio of neurology, inflammation, and pain medications. Its products include INDOCIN, Sympazan, Otrexup, SPRIX, CAMBIA, and Zipsor. The company was founded on August 7, 1995 and is headquartered in Lake Forest, IL.

Assertio Holdings Inc

Assertio Holdings is facing intense scrutiny and shareholder frustration as investors actively discuss the company's discounted merger agreement with Garda Therapeutics and the perceived undervaluation of its core assets. The community is heavily focused on the potential to block the acquisition through legal injunctions or by organizing voting blocks, as many feel the tender offer fails to reflect the company's true value and cash position.

Sei is a high-performance Layer 1 blockchain that scales the EVM with parallelized execution, enabling faster transactions, low fees, and seamless smart contract deployment. Sei removes traditional blockchain bottlenecks while maintaining full Ethereum compatibility. The upcoming Giga upgrade will deliver 50x improvements in EVM throughput, optimizing execution, consensus, and storage to push blockchain performance to web2 levels.

Sei is experiencing renewed community focus as investors track its potential as a high-performance Layer-1 blockchain, with active discussions centering on upcoming network upgrades and its growing role in real-world asset tokenization. Traders are debating the project's long-term utility versus its recent price volatility, while many remain optimistic about its capacity to capture institutional interest and scale within the DeFi ecosystem.

The 401jK (just kidding) meme is a satirical punch in the gut in the face of the concept of retirement and the popular US based 401(k) retirement plan and other pension plans around the world  Through the meme fueled humor, irony, satire &amp; inspiration from cypherpunk ideology, real life data, and current events... the 401jK community aims to comment on the fact that global markets are heavily manipulated for selfish purposes by the same people who control these pension funds... while also aiming to twist the heads of the 401k and global pension systems.  It is a retirement plan that seeks to make social, political, economic commentary fueled by the memes and dreams of the hive mind of the community that makes up 401jK  The rules have changed, and the game was always rigged.  It's time to wake up, adapt, rebel, and heal.  Welcome to 401jK

401jK

401jK is gaining momentum as a community-driven project that uses memes to challenge the traditional retirement system and advocate for financial independence. The community is actively discussing its grassroots narrative, focusing on IRL raids and educational content while positioning the token as a rebellious alternative to corporate savings plans.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Allurion Intends to Appeal NYSE Notice of Delisting, Execute Plan to Regain Compliance, and Expects to Continue Trading on NYSE

Allurion Technologies, Inc. (the Company) (NYSE: ALUR), a pioneer in metabolically healthy weight loss, has received notice from the New York Stock Exchange (NYSE) that it intends to initiate...

Are Medical Stocks Lagging  Allurion Technologies, Inc. (ALUR) This Year?

Here is how Allurion Technologies, Inc. (ALUR) and McKesson (MCK) have performed compared to their sector so far this year.

Allurion Announces Exercise of Warrants for $3.0 Million in Gross Proceeds

Allurion Technologies, Inc. (NYSE: ALUR) (the Company or Allurion), a pioneer in metabolically healthy weight loss, today announced the entry into a definitive agreement for the immediate exercise of...

Power Hour Surge: Cover Story, FDA Catalysts, Rare Earths, and a $7.8B Biotech Buyout

As the final hour of trading unfolds, momentum is clustering around breakthrough science, regulatory catalysts, strategic commodities, and headline M&A. Here are the stocks commanding attention into the close and potentially into afterhours.

<ul class="summary-bullets"><li>The Allurion Smart Capsule is designed to be taken without surgery, endoscopy, or anesthesia.</li><li>Once swallowed, the capsule is filled with fluid and remains in the stomach for roughly 4 months, helping patients feel fuller and reducing food intake.</li><li>The company said the Capsule offers a safe and effective alternative to GLP-1 medications.&nbsp;</li></ul>Allurion Technologies Inc. (ALUR) announced on Monday that the U.S. Food and Drug Administration (FDA) has granted premarket approval (PMA) for its Allurion Gastric Balloon System, clearing the way for the company to expand its non-surgical weight-loss treatment across the United States.The FDA authorized the company’s PMA application for the system, which features the swallowable Allurion Smart Capsule.&nbsp;<h2 class="st-heading-2">How Does The Smart Capsule Work?&nbsp;</h2>The Allurion Smart Capsule is designed to be taken without surgery, endoscopy, or anesthesia. Once swallowed, the capsule is filled with fluid and remains in the stomach for roughly 4 months, helping patients feel fuller and reducing food intake.At the end of that period, a built-in release mechanism allows the device to deflate and pass naturally through the body. Patients may begin another treatment cycle about two months later. Unlike daily pills or weekly injections, the system provides several months of therapy from a single administration.Following the update,&nbsp;<a href="https://stocktwits.com/symbol/ALUR">Allurion’s stock</a> traded over 50% higher on Monday morning. On Stocktwits, retail sentiment around the stock changed to ‘extremely bullish’ from ‘bullish’ territory the previous day. Message volume shifted to ‘extremely high’ from ‘normal’ levels in 24 hours.&nbsp;<figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_02_23_095601_png_3a2e82b97f.webp" alt="ALUR’s Sentiment Meter and Message Volume as of 09:50 a.m. ET on Feb. 23, 2026 | Source: Stocktwits" width="933" height="106"><figcaption>ALUR’s Sentiment Meter and Message Volume as of 09:50 a.m. ET on Feb. 23, 2026 | Source: Stocktwits</figcaption></figure><h2 class="st-heading-2">Addressing A Large U.S. Market</h2>More than 100 million Americans are affected by obesity, with approximately 80 million individuals falling within the body mass index range of 30 to 40 kg/m2, which qualifies them for the Smart Capsule.&nbsp;<blockquote>“The Allurion Smart Capsule offers a safe and effective alternative to GLP-1s and bariatric surgery, and it should become a standard tool in the comprehensive treatment of obesity in the United States.”-Shantanu Gaur, Founder and CEO, Allurion</blockquote>The company also pointed to high discontinuation rates among GLP-1 medications, noting that many patients stop treatment within a year, often regaining lost weight.ALUR stock has gained over 27% in the last 12 months.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/djt-stock-draws-bearish-retail-buzz-on-tariff-turmoil-and-supreme-court-ruling/cZRtsOBR4yh">DJT Stock Draws Bearish Retail Buzz On Tariff Turmoil And Supreme Court Ruling</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Someone holding a pharmaceutical capsule.

Why Did Allurion Stock Surge Over 50% Today?

The U.S. Food and Drug Administration has granted premarket approval for Allurion’s Gastric Balloon System with the swallowable Allurion Smart Capsule.

Equity

Allurion Receives U.S. FDA Approval

Allurion Technologies, Inc. (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced that the U.S. Food and Drug Administration (FDA) has approved the premarket approval (PMA...

Allurion Announces Partnership to Offer Combination Therapy with Mounjaro (tirzepatide) at Discounted Prices

Allurion Technologies, Inc. (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced a partnership with Bionut, a leader in obesity care in Argentina, and Farmastar, a local...

Allurion Announces Preliminary Fourth Quarter and Full-Year 2025 Results

Allurion Technologies, Inc. (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced preliminary, unaudited results for the fourth quarter and full year 2025. Management expects...

New Peer-Reviewed Publication Demonstrates Superior Weight Loss and Improved Body Composition with the Allurion Smart Capsule Combined with Lifestyle Intervention Compared to Lifestyle Intervention Alone

Allurion Technologies, Inc. (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced the publication of a peer-reviewed, case-controlled study on the use of the Allurion Smart...

Allurion Announces Strategic Distribution Partnership with ProSurg Medical in Brazil to Pioneer New Approach Focused on Metabolically Healthy Weight Loss

Allurion Technologies, Inc. (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced a strategic distribution partnership with ProSurg Medical, a leading Brazilian medical device...

$ALUR Q4 &#39;25 Earnings Results &amp; Recap

Allurion is directing efforts to become EBITDA positive in 2026 through cost reduction initiatives, but expects continued operating losses and faces substantial doubt about its ability to continue as a going concern.

Stocktwits

Allurion Technologies Inc

 Q4 '25 Earnings Results & Recap

Allurion is directing efforts to become EBITDA positive in 2026 through cost reduction initiatives, but expects continued operating losses and faces substantial doubt about its ability to continue as a going concern.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

Allurion Technologies, Inc. develops treatments for obesity. The Allurion Program is a weight loss platform that combines the Allurion Gastric Balloon, a swallowable, procedure-less gastric balloon for weight loss, the Allurion Virtual Care Suite including the Allurion Mobile App for consumers, Allurion Insights for health care providers featuring the Iris AI Platform, and the Allurion Connected Scale and Health Tracker devices. The Allurion Virtual Care Suite is also available to providers separately from the Allurion Program to help customize, monitor and manage weight loss therapy for patients regardless of their treatment plan: gastric balloon, surgical, medical or nutritional. The company was founded on January 25, 2023 and is headquartered in Natick, MA.

ALUR
Allurion Technologies Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Earnings Recap

Latest ALUR News

ALURAllurion Technologies Inc